Key result
Cangrelor infusion during PCI for acute myocardial infarction complicating ischemic stroke was successful in two patients, with no ischemic or hemorrhagic complications during the in-hospital stay.
Why the study?
Acute myocardial infarction complicating ischemic stroke is undertreated due to hemorrhagic risk, and the optimal antiplatelet regimen during primary PCI has not been clearly defined.
Does cangrelor infusion prevent ischemic and hemorrhagic complications in patients with acute myocardial infarction complicating ischemic stroke undergoing PCI?
Case Report (n=2)
Does cangrelor infusion prevent ischemic and hemorrhagic complications in patients with acute myocardial infarction complicating ischemic stroke undergoing PCI?
Cangrelor bridge therapy may be a safe and feasible antiplatelet strategy for patients requiring primary PCI for AMI complicated by recent ischemic stroke.
Answers are grounded in this paper and cite their sources.
May support cangrelor bridging in this rare scenario; leaves open safety and efficacy pending prospective trials.
Acute myocardial infarction (AMI) complicating ischemic stroke is a well known and undertreated event. A conservative management is not infrequent in these settings, due to the fear of hemorrhagic complications related to antithrombotic therapy. Notably, an invasive approach with a primary percutaneous coronary intervention (PCI) has been shown to be associated with a lower in-hospital mortality in patients with concomitant ischemic stroke and AMI. The optimal antiplatelet regimen in these cases has been not clearly defined, yet. We report two cases of patients with AMI complicating ischemic stroke, successfully treated with cangrelor infusion, which was started during PCI and maintained up to 48 h at bridge therapy dosage (0.75 mcg/kg/min). Both patients underwent successful PCI in the acute phase, and neither ischemic nor hemorrhagic complications occurred during in-hospital stay.
No takes yet. Share an insight, caveat, or question.
Morici et al. (2019) conducted a case report in Acute myocardial infarction complicating ischemic stroke (n=2). Cangrelor infusion was evaluated on Ischemic or hemorrhagic complications during in-hospital stay. Cangrelor infusion during PCI for acute myocardial infarction complicating ischemic stroke was successful in two patients, with no ischemic or hemorrhagic complications during the in-hospital stay.
Synapse has enriched 10 related papers. Consider them for comparative context: